The identification of the mechanisms underlying the aberrant regulation of HIF-1α and HIF-2α leading to persistent inflammation and Th1/Th17 pathology in sarcoidosis should open new avenues in rational drug discovery, not only for this disease but also for other inflammatory diseases. The gene discussed is EPAS1; the disease is sarcoidosis.